HIV‐1 viral load determination based on reverse transcriptase activity recovered from human plasma
- 4 September 2003
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 71 (3) , 347-359
- https://doi.org/10.1002/jmv.10492
Abstract
We describe a procedure (ExaVir™ Load) to carry out human immunodeficiency virus‐1 (HIV‐1) viral load testing using reverse transcriptase (RT) recovered from HIV‐1 virions in plasma. Samples from individuals infected with HIV‐1 were treated with a sulphydryl‐reactive agent to inactivate endogenous polymerases. Virions were then immobilised on a gel and washed in individual mini columns to remove RT‐inhibiting antibodies, antiviral drugs, and other RT inhibitors. Immobilised virions were lysed finally, and the viral RT eluted. The amount of RT recovered was quantified by a sensitive RT activity assay using either colorimetry or fluorimetry to detect DNA produced by RT. The “RT load” values of 390 samples from 302 HIV‐1 patients living in Sweden were compared to results obtained with an HIV‐1 RNA viral load assay. The correlation between the two tests was r = 0.90, P < 0.0001. Four of 202 samples from healthy blood donors gave low positive values in the RT test. All samples in a panel with 10 HIV‐1 subtypes were positive by the RT load. The RT load test provides a technically less demanding and cost‐effective alternative to methods based on nucleic acid amplification. Being insensitive to genetic drift occurring in HIV, the assay should be of particular use in resource‐limited settings, where different subtypes and recombinant HIV strains occur. J. Med. Virol. 71:347–359, 2003.Keywords
This publication has 35 references indexed in Scilit:
- Use of HIV-1 reverse transcriptase recovered from human plasma for phenotypic drug susceptibility testingAIDS, 2003
- A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypesAIDS, 2003
- Prospective Evaluation of Amplification‐Boosted ELISA for Heat‐Denatured p24 Antigen for Diagnosis and Monitoring of Pediatric Human Immunodeficiency Virus Type 1 InfectionThe Journal of Infectious Diseases, 1999
- A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identityJournal of Virological Methods, 1998
- Measurement of Human Immunodeficiency Virus Type 1 Plasma Virus Load Based on Reverse Transcriptase (RT) Activity: Evidence of Variabilities in Levels of Virion‐Associated RTThe Journal of Infectious Diseases, 1998
- Differences in Reverse Transcriptase Activity versus p24 Antigen Detection in Cell Culture, When Comparing a Homogeneous Group of HIV Type 1 Subtype B Viruses with a Heterogeneous Group of Divergent StrainsAIDS Research and Human Retroviruses, 1998
- Most HIV-1 genetic subtypes have entered SwedenAIDS, 1997
- Longitudinal Analysis of Quantitative Virologic Measures in Human Immunodeficiency Virus-Infected Subjects with >=400 CD4 Lymphocytes: Implications for Applying Measurements to Individual PatientsThe Journal of Infectious Diseases, 1997
- The feline lymphoid cell line MBM and its use for feline immunodeficiency virus isolation and quantitationVeterinary Immunology and Immunopathology, 1995
- HIV reverse transcriptase inhibiting antibodies detected by a new technique: Relation to p24 and gp41 antibodies, HIV antigenemia and clinical variablesJournal of Medical Virology, 1991